作者: Diane Williamson
DOI: 10.1155/2014/395302
关键词:
摘要: This review considers the steps required to evaluate a candidate biodefense vaccine or therapy as it emerges from research phase, in order transition development. The options for preclinical modelling of efficacy are considered context FDA's Animal Rule.